- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
"Throughout 2018, the global biopharma industry’s opinion of the UK as an attractive place to base research and manufacturing has steadily eroded and last night’s vote will have done nothing to improve this sentiment with the looming possibility of a ‘No Deal Brexit’"
1 in 9 UK shoppers to return Christmas gifts, with pyjamas the most unwanted present of them all
While the impact of Boxing Day sales is waning due to the growing emphasis on Black Friday and the heavy discounting that retailers are engaging in before Christmas, the day will still be notable for the high levels of returns that stores will process, due to unwanted Christmas presents.
Immuno-oncology drug development and personalized medicine will continue to reshape the pharmaceutical industry in 2019
Immuno-oncology (I-O) drug development will remain at the forefront of the pharmaceutical industry in 2019, says GlobalData, a leading data and analytics company.
Telcos seek alternative approaches to enter the saturated mobile financial services sector in Europe
Mobile Financial Services (MFS) in Europe have grown rapidly over the last five years, due to the proliferation of mobile applications and relatively high smartphone penetration, according to GlobalData, a leading data and analytics company.
Value of online returns to rise to £5.6bn by 2023, driven by clothing & footwear
Online returns will increase by 27.3% over the next five years to £5.6bn, but this rapid growth represents a lower return rate as online spending will rise even faster, according to GlobalData, a leading data and analytics company.
Integrating Amazon Alexa into healthcare could lead to better patient engagement and increased compliance with treatment regimens
By utilizing its Alexa devices and apps, Amazon has the potential to bring more patient-focused care to help people with chronic disease management such as diabetes and heart failure, connect their health data with medical professionals, and enable integration with other devices and apps, says GlobalData, a leading data and analytics company.
Eli Lilly’s $2bn deal highlights the increased focus on anti-tau therapies for Alzheimer’s disease
Following the news (12th December 2018) that AC Immune and Eli Lilly have signed a collaboration agreement to research and develop tau aggregation inhibitors for the potential treatment of Alzheimer's disease (AD), and other neurodegenerative diseases,
Competition in Multiple Sclerosis market set to increase with launch of new pipeline drugs and entry of new generics
The Multiple Sclerosis (MS) therapeutics market has entered an exciting phase, with an upsurge of available treatment options and several promising late-stage pipeline products offering diverse mechanisms of action (MOAs). The launch of 12 new therapies will drive growth in the MS space, provide more options for patients, and stimulate further competition, says GlobalData, a leading data and analytics company.
Five cosmetic trends that transformed the industry in 2018
The cosmetics industry saw some game-changing trends and innovations in 2018. Iliyana Mesheva, Consumer Analyst at GlobalData, a leading data and analytics company, identifies five key trends:
Global atopic dermatitis market set to reach $18.3bn by 2027
The atopic dermatitis market is expected to grow from $6.4bn in 2017 to $18.3bn in 2027 across the seven major markets (7MM*) at a compound annual growth rate (CAGR) of 11.1%, according to GlobalData, a leading data and analytics company.
Second failure of AstraZeneca’s Imfinzi + tremelimumab combination in two months significant setback for the combination, but not the company
Following the news (Friday 7 December) that the combination did not improve overall survival versus standard-of-care chemotherapy in metastatic head and neck cancer previously treated with platinum-based chemotherapy, it appears AstraZeneca’s investment may not pay off,
Pharma companies may miss crucial EU drug packaging deadline in event of a no-deal Brexit
Many EU and US pharma companies are unaware that if a no-deal Brexit is reached between the UK and the EU, they will need to meet a crucial EU export administration deadline by March 29, 2019, a regulatory expert has confirmed.
83% of UK healthcare professionals now say the UK WILL NOT be an attractive destination for healthcare research and manufacturing after Brexit
Healthcare industry professionals around the world have confirmed that the UK will not be as attractive a destination for research and manufacturing after Brexit in the latest survey from GlobalData, a leading data and analytics company.
Kellogg’s respond to consumer demand for transparency with traffic light labelling
Following the news that from January 2019, Kellogg’s are to adopt the traffic light labels to show fat, sugar and salt levels in its products,
Majority of pharma professionals now say Brexit will have a negative impact on the UK healthcare sector
Negative sentiment amongst healthcare professionals about the impact of Brexit on the UK healthcare sector has increased over the last 3 months, according to GlobalData, a leading data and analytics company.
Millennials are driving the market for non-alcoholic beer in the UK
The importance of health and wellbeing among millennials remains crucial to the projected rise of non-alcoholic beer consumption in the UK, says GlobalData, a leading data and analytics company.
Failing to engage with sole traders is holding back insurers in SME market
The UK small and medium-sized enterprises (SME) insurance market registered a 3.6% growth in 2017, but remains flat in recent years, despite the number of businesses in the UK continuing to grow year-on-year, says GlobalData, a leading data and analytics company.
Morgan Stanley leads Oil & Gas sector in GlobalData’s M&Amp;A financial advisers ranking Q2 2018
Morgan Stanley has claimed the top position in the latest Oil & Gas Industry M&A financial advisers M&A league table for Q2 2018, compiled by leading data analytics company GlobalData.
Bank of America Merrill Lynch leads power sector in GlobalData’s Q2 M&A financial adviser rankings
Bank of America (BofA) Merrill Lynch has claimed the top spot in the latest power industry financial advisers M&A league table for Q2 2018, compiled by leading data analytics company GlobalData.
Morgan Stanley leads GlobalData’s global M&A financial adviser league table in the Metals & Mining Sector for Q3 2018
Morgan Stanley has topped the latest M&A league table of the top 10 financial advisers for the Metals & Mining industry for Q3 2018, compiled by GlobalData, a leading data analytics company.